ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

15,711Medicare Part D Prescriptions Filled, Including Refills

Rank: 105 out of 939

$747K Total Retail Price of All Prescriptions

Rank: 106 out of 939

736 Patients Receiving at Least One Drug in Part D
65%Patients 65 Years and Older
63% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Arkansas
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 736 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

24% of this provider’s 736 patients filled at least one prescription for a schedule three drug, compared to an average of 19%.

Risky Drugs to Seniors

4% of this provider’s 9,546 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$48 was the average price of a prescription from this provider, compared to $49 among peers.

Prescriptions per Patient

21 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Arkansas
LEVOTHYROXINE SODIUM 692 547 1 4
HYDROCODONE-ACETAMINOPHEN 569 253 S3 2 1
METOPROLOL TARTRATE 451 276 3 10
FUROSEMIDE 377 247 4 7
LISINOPRIL-HYDROCHLOROTHIAZIDE 337 191 5 23
MELOXICAM 333 225 6 14
LISINOPRIL 330 264 7 3
POTASSIUM CHLORIDE 324 245 8 9
AMLODIPINE BESYLATE 308 226 9 6
OMEPRAZOLE 308 205 9 5
METFORMIN HCL 300 147 11 8
SIMVASTATIN 266 145 12 2
METOPROLOL SUCCINATE 255 168 13 21
GABAPENTIN 247 146 14 11
ZOLPIDEM TARTRATE 226 109 15 20
CITALOPRAM HBR 215 116 16 15
NEXIUM 207 87 17 18
WARFARIN SODIUM 185 148 18 17
FLUTICASONE PROPIONATE 181 128 19 43
ATENOLOL 171 109 20 19
CLONIDINE HCL 162 103 21 39
TRAZODONE HCL 151 86 22 26
TIZANIDINE HCL 148 20 23 81
TRAMADOL HCL 135 48 24 16
RANITIDINE HCL 134 62 25 35
TRIAMTERENE-HYDROCHLOROTHIAZID 127 80 26 115
SERTRALINE HCL 124 70 27 24
ISOSORBIDE MONONITRATE ER 123 95 28 53
CLOPIDOGREL 120 99 29 28
CYCLOBENZAPRINE HCL 119 40 R 30 36
AMOXICILLIN 115 63 31 92
INDOMETHACIN 112 66 R 32 239
CIPROFLOXACIN HCL 110 70 33 54
AZITHROMYCIN 108 72 34 32
GLYBURIDE 108 55 R 34 89
AMITRIPTYLINE HCL 107 37 R 36 38
PRENATAL PLUS 102 79 37 246
SULFAMETHOXAZOLE-TRIMETHOPRIM 98 63 38 64
GLIPIZIDE 97 65 39 52
POLYETHYLENE GLYCOL 3350 97 68 39 57
DILTIAZEM ER 90 58 41 94
BUMETANIDE 89 78 42 124
CLOTRIMAZOLE-BETAMETHASONE 89 69 42 188
DETROL LA 85 56 44 155
CARVEDILOL 85 59 44 25
PROMETHAZINE HCL 84 16 R 46 68
LYRICA 82 28 47 63
CYMBALTA 82 17 47 44
ADVAIR DISKUS 82 46 47 60
GLIMEPIRIDE 80 38 50 37
DIGOXIN 80 63 50 45
PLAVIX 78 58 52 48
PROAIR HFA 77 47 53 41
TAMSULOSIN HCL 77 56 53 27
CARISOPRODOL 76 21 R 55 51
QUETIAPINE FUMARATE 75 58 56 69
VENTOLIN HFA 75 20 56 80
TRIAMTERENE-HCTZ 72 47 58 33
NIFEDIPINE ER 68 39 59 105
JANUMET 65 47 60 224
SUCRALFATE 65 34 60 96
HYDROXYZINE HCL 64 39 R 62 206
LOSARTAN-HYDROCHLOROTHIAZIDE 63 21 63 55
PREMARIN 63 27 R 63 111
MIRTAZAPINE 63 39 63 56
PRAVASTATIN SODIUM 63 55 63 13
MECLIZINE HCL 62 55 67 134
DIOVAN HCT 62 55 67 74
FINASTERIDE 62 25 67 131
ALLOPURINOL 62 55 67 31
ESTRADIOL 61 31 R 71 79
JANUVIA 61 20 71 110
GEMFIBROZIL 57 37 73 100
HYDROCHLOROTHIAZIDE 57 33 73 12
GLYBURIDE-METFORMIN HCL 56 49 R 75 98
AMLODIPINE BESYLATE-BENAZEPRIL 55 55 76 58
ENALAPRIL MALEATE 55 42 76 65
NAPROXEN 54 28 78 72
LOVASTATIN 54 18 78 46
FLUCONAZOLE 53 32 80 140
DILTIAZEM 24HR CD 51 26 81 126
DONEPEZIL HCL 51 51 81 30
CELEBREX 50 36 83 106
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 16, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.